Annual CFO
-$70.94 M
+$49.19 M+40.95%
31 December 2023
Summary:
Mirum Pharmaceuticals annual cash flow from operations is currently -$70.94 million, with the most recent change of +$49.19 million (+40.95%) on 31 December 2023. During the last 3 years, it has risen by +$61.81 million (+46.56%). MIRM annual CFO is now -80.23% below its all-time high of -$39.36 million, reached on 31 December 2019.MIRM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$3.98 M
+$7.79 M+204.76%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly cash flow from operations is currently $3.98 million, with the most recent change of +$7.79 million (+204.76%) on 30 September 2024. Over the past year, it has increased by +$20.60 million (+123.97%). MIRM quarterly CFO is now -73.81% below its all-time high of $15.21 million, reached on 31 March 2024.MIRM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$1.23 M
+$22.20 M+94.77%
30 September 2024
Summary:
Mirum Pharmaceuticals TTM cash flow from operations is currently -$1.23 million, with the most recent change of +$22.20 million (+94.77%) on 30 September 2024. Over the past year, it has increased by +$69.72 million (+98.27%). MIRM TTM CFO is now at all-time high.MIRM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +124.0% | +98.3% |
| 3 y3 years | +46.6% | +112.0% | +99.1% |
| 5 y5 years | -80.2% | +129.1% | +96.9% |
MIRM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.6% | -73.8% | +110.0% | at high | +99.2% |
| 5 y | 5 years | -80.2% | +46.6% | -73.8% | +109.9% | at high | +99.2% |
| alltime | all time | -80.2% | +46.6% | -73.8% | +109.9% | at high | +99.2% |
Mirum Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.98 M(-204.8%) | -$1.23 M(-94.8%) |
| June 2024 | - | -$3.80 M(-125.0%) | -$23.43 M(-36.6%) |
| Mar 2024 | - | $15.21 M(-191.5%) | -$36.96 M(-47.9%) |
| Dec 2023 | -$70.94 M(-40.9%) | -$16.62 M(-8.8%) | -$70.94 M(-19.9%) |
| Sept 2023 | - | -$18.22 M(+5.1%) | -$88.60 M(-8.1%) |
| June 2023 | - | -$17.33 M(-7.7%) | -$96.40 M(-2.9%) |
| Mar 2023 | - | -$18.77 M(-45.2%) | -$99.24 M(-17.4%) |
| Dec 2022 | -$120.14 M(-9.5%) | -$34.27 M(+31.7%) | -$120.14 M(+0.9%) |
| Sept 2022 | - | -$26.02 M(+29.0%) | -$119.01 M(-6.4%) |
| June 2022 | - | -$20.17 M(-49.1%) | -$127.19 M(-13.6%) |
| Mar 2022 | - | -$39.67 M(+19.7%) | -$147.22 M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$132.76 M(+49.0%) | -$33.15 M(-3.1%) | -$132.76 M(-2.3%) |
| Sept 2021 | - | -$34.20 M(-14.9%) | -$135.89 M(+14.1%) |
| June 2021 | - | -$40.20 M(+59.5%) | -$119.14 M(+24.2%) |
| Mar 2021 | - | -$25.21 M(-30.5%) | -$95.93 M(+7.7%) |
| Dec 2020 | -$89.08 M(+126.3%) | -$36.28 M(+107.9%) | -$89.08 M(+34.0%) |
| Sept 2020 | - | -$17.45 M(+2.7%) | -$66.49 M(+3.5%) |
| June 2020 | - | -$16.99 M(-7.4%) | -$64.26 M(+16.2%) |
| Mar 2020 | - | -$18.35 M(+34.0%) | -$55.29 M(+40.5%) |
| Dec 2019 | -$39.36 M | -$13.70 M(-10.0%) | -$39.36 M(+53.4%) |
| Sept 2019 | - | -$15.22 M(+89.9%) | -$25.66 M(+145.8%) |
| June 2019 | - | -$8.02 M(+230.5%) | -$10.44 M(+330.5%) |
| Mar 2019 | - | -$2.43 M | -$2.43 M |
FAQ
- What is Mirum Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly CFO year-on-year change?
- What is Mirum Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM CFO year-on-year change?
What is Mirum Pharmaceuticals annual cash flow from operations?
The current annual CFO of MIRM is -$70.94 M
What is the all time high annual CFO for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual cash flow from operations is -$39.36 M
What is Mirum Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of MIRM is $3.98 M
What is the all time high quarterly CFO for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly cash flow from operations is $15.21 M
What is Mirum Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, MIRM quarterly cash flow from operations has changed by +$20.60 M (+123.97%)
What is Mirum Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of MIRM is -$1.23 M
What is the all time high TTM CFO for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM cash flow from operations is -$1.23 M
What is Mirum Pharmaceuticals TTM CFO year-on-year change?
Over the past year, MIRM TTM cash flow from operations has changed by +$69.72 M (+98.27%)